primaquine has been researched along with Carcinoma, Epidermoid in 1 studies
Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'iakonova, MIu | 1 |
| Sorkin, AD | 1 |
| Nikol'skiĭ, NN | 1 |
1 other study available for primaquine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
[The effect of the lysosomotropic agent primaquine on the endocytosis of the epidermal growth factor receptors in A431 cells].
Topics: Carcinoma, Squamous Cell; Endocytosis; Epidermal Growth Factor; ErbB Receptors; Fluorescent Antibody | 1992 |